Paradoxical negative HDL cholesterol response to atorvastatin and simvastatin treatment in Chinese type 2 diabetic patients.
Explore this paper's citation graph
Summary
Diabetic patients, except those with severe atherogenic dyslipidemia, are prone to a decrease in serum HDL-C level after statin treatment, particularly after atorvastatin treatment.
- Type
- article
- Published
- 2013-01-01
- Cited by
- 9
- References
- 39
- Access
- Open access
- OpenAlex
- https://openalex.org/W15811929
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:41148909
Keywords
Simvastatin, Atorvastatin, Internal medicine, Medicine, Cholesterol
References
- UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
- Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus
- ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.
- Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes.
- Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes
- CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review
- Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
- Low HDL‐cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan‐European survey
- CYP3AP1*3 Allele Is Associated With Lipid‐Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women
- Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
- Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
- Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.
- Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
- Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER.
- Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials
- Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit
- Do structural differences in statins correlate with clinical efficacy?
Cited by
- Anti-hyperglycemic and hypolipidemic effects of baechukimchi with Ecklonia cava in type 2 diabetic db/db mice
- Changes in high-density-lipoprotein cholesterol upon statin treatment in type 2 diabetic patients: a meta-analysis.
- Preliminary study on the efficacy and safety of atorvastatin in northern Han patients with acuteischemic cerebrovascular disease
- The effect of the Conversation Map program in patients with poor glycemic control with type 2 diabetes mellitus-when usual care is not enough
- Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes.
- The effect of Cytochrome P450 7A1(CYP7A1) polymorphism on lipid responses to simvastatin treatment.
- Sex disparities in the effect of statins on lipid parameters
- Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis
- Sex disparities in the effect of statins on lipid : The PharmLines Initiative
- The effect of simplified paired self-monitoring of blood glucose in patients with type 2 diabetes mellitus with persistent poor glycemic control
Related papers
- Efficacy of Atorvastatin Compared With Simvastatin in Patients With Hypercholesterolemia
- Cost-Effectiveness Analysis of Atorvastatin and Simvastatin of Lipid Efficacy
- Comments on “CYP3AP1*3 Allele Is Associated With Lipid‐Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women”
- Mechanism of cholesterol lowering in casein-fed rabbits treated with atorvastatin
- [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
- Lifestyle Change Alone Sufficient to Lower Cholesterol in Male Patient With Moderately Elevated Cholesterol: A Case Report
- Importance of dietary cholesterol in man.
- Efficacy of atorvastatin in primary hypercholesterolemia. Japan Cholesterol Lowering Atorvastatin Study (J-CLAS) Group.
- Inhibition of Dietary Cholesterol Absorption During Lovastatin (Mevinolin) Treatment